SCHEMBL19082327

SCHEMBL19082327

c1ccc(-c2c3ccccc3c(-c3ccc(-c4cc5sc6c7ccccc7ccc6c5c5sc6ccccc6c45)c4ccccc34)c3ccccc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 5/20 0.41
CYP1B1 Q16678 5/20 0.41
PTPN1 P18031 3/20 0.35
CYP1A2 P05177 4/20 0.34
NQO1 P15559 1/20 0.33
NQO2 P16083 1/20 0.33
TNKS O95271 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
F9 P00740 1/20 0.33
SOS1 Q07889 1/20 0.32
PTPRC P08575 1/20 0.32
PTPRF P10586 1/20 0.32
PTPRA P18433 1/20 0.32
PTPRB P23467 1/20 0.32
PTPN6 P29350 1/20 0.32
DUSP3 P51452 1/20 0.32
PTPN12 Q05209 1/20 0.32
ESR1 P03372 2/20 0.31
ESR2 Q92731 2/20 0.31
MEN1 O00255 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082101 0.94 CYP1A1 (0.44) CYP1A1CYP1B1PTPN1CYP1A2NQO1
SCHEMBL19082154 0.91 CYP1A1 (0.42) CYP1A1CYP1B1PTPN1CYP1A2NQO1
SCHEMBL17945724 0.91 PTPN1 (0.39) PTPN1TNKSTNKS2F9PTPRC
SCHEMBL19082230 0.90 CYP1A1 (0.43) CYP1A1CYP1B1PTPN1CYP1A2NQO1
SCHEMBL19082367 0.90 CYP1A1 (0.37) CYP1A1CYP1B1PTPN1CYP1A2NQO1
SCHEMBL19080301 0.89 CYP1A1 (0.44) CYP1A1CYP1B1CYP1A2NQO1NQO2
SCHEMBL19082265 0.88 CYP1A1 (0.44) CYP1A1CYP1B1PTPN1CYP1A2NQO1
SCHEMBL19082239 0.87 CA12 (0.38) CYP1A1CYP1B1PTPN1CYP1A2NQO1
SCHEMBL19082347 0.87 CYP1A1 (0.40) CYP1A1CYP1B1PTPN1CYP1A2NQO1
SCHEMBL19082114 0.85 CYP1A1 (0.39) CYP1A1CYP1B1PTPN1CYP1A2NQO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885PTPN1 4695/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885PTPN1 4695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.